Detection of occult tumor cells in lymph nodes from non-small cell lung cancer patients using reverse transcription-polymerase chain reaction for carcinoembryonic antigen mRNA with the evaluation of its sensitivity

Lung Cancer

Volumn 52, Issue 2, 2006, Pages 235-240

  Maeda, Jun ^a   Inoue, Masayoshi ^a   Okumura, Meinoshin ^a   Ohta, Mitsunori ^a   Minami, Masato ^a   Shiono, Hiroyuki ^a   Shintani, Yasushi ^a   Matsuda, Hikaru ^a   Matsuura, Nariaki ^b  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Carcinoembryonic antigen; Lung cancer; Micrometastasis; Occult tumor cell; Real time quantitative reverse transcription polymerase chain reaction

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; EOSIN; HEMATOXYLIN; MESSENGER RNA;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER DIAGNOSIS; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE AMPLIFICATION; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LOBECTOMY; LUNG ADENOMA; LUNG NON SMALL CELL CANCER; LYMPH NODE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MALE; MICROMETASTASIS; OCCULT CANCER; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; STAINING; STATISTICAL SIGNIFICANCE; TUMOR; TUMOR CELL;

ADULT; AGED; AGED, 80 AND OVER; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY;

EID: 33645988565     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2005.12.008     Document Type: Article

References (25)

1. Jemal A., Murray T., Ward E., Samuels A., Tiwari R.C., Ghafoor A., et al. Cancer statistics, 2005. CA Cancer J Clin 55 (2005) 10-30
2. Smythe W.R., and American College of Chest Physicians. Treatment of Stage I non-small cell lung carcinoma. Chest 123 (2003) 181-187
3. Gu C.D., Osaki T., Oyama T., Inoue M., Kodate M., Dobashi K., et al. Detection of micrometastatic tumor cells in pN0 lymph nodes of patients with completely resected non-small cell lung cancer: impact on recurrence and survival. Ann Surg 235 (2002) 133-139
4. Wu J., Ohta Y., Minato H., Tsunezuka Y., Oda M., Watanabe Y., et al. Nodal occult metastasis in patients with peripheral lung adenocarcinoma of 2.0 cm or less in diameter. Ann Thorac Surg 71 (2001) 1772-1777
5. Hashimoto T., Kobayashi Y., Ishikawa Y., Tsuchiya S., Okumura S., Nakagawa K., et al. Prognostic value of genetically diagnosed lymph node micrometastasis in non-small cell lung carcinoma cases. Cancer Res 60 (2000) 6472-6478
6. Kijima F., Natsugoe S., Takao S., Aridome K., Baba M., Yoshifumi M., et al. Detection and clinical significance of lymph node micrometastasis determined by reverse transcription-polymerase chain reaction in patients with esophageal carcinoma. Oncology 58 (2000) 38-44
7. Kubota K., Nakanishi H., Hiki N., Shimizu N., Tsuji E., Yamagichi H., et al. Quantitative detection of micrometastases in the lymph nodes of gastric cancer patients with real-time RT-PCR: a comparative study with immunohistochemistry. Int J Cancer 105 (2003) 136-143
8. Noura S., Yamamoto H., Ohnishi T., Masuda N., Matsumoto T., Takayama O., et al. Comparative detection of lymph node micrometastases of stage II colorectal cancer by reverse transcriptase polymerase chain reaction and immunohistochemistry. J Clin Oncol 20 (2002) 4232-4241
9. D'Cunha J., Corfits A.L., Herndon II JE., Kern J.A., Kohman L.J., Patterson G.A., et al. Molecular staging of lung cancer: real-time polymerase chain reaction estimation of lymph node micrometastatic tumor cell burden in stage I non-small cell lung cancer-preliminary results of Cancer and Leukemia Group B Trial 9761. J Thorac Cardiovasc Surg 123 (2002) 484-491
10. Arriagada R., Bergman B., Dunant A., Le Chevalier T., Pignon J.P., Vansteenkiste J., and International Adjuvant Lung Cancer Trial Collaborative Group. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Eng J Med 350 (2004) 351-360
11. Kato H., Ichinose Y., Ohta M., Hata E., Tsubota N., Tada H., et al., Ohta M., Japan Lung Cancer Research Group on Post surgical Adjuvant Chemotherapy. A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. N Eng J Med 350 (2004) 1713-1721
12. Osaki T., Oyama T., Gu C.D., Yamashita T., So T., Takenoyama M., et al. Prognostic impact of micrometastatic tumor cells in the lymph nodes and bone marrow of patients with completely resected stage I non-small-cell lung cancer. J Clin Oncol 20 (2002) 2930-2936
13. Goldstein N.S., Mani A., Chmielewski G., Welsh R., and Pursel S. Immunohistochemically detected micrometastases in peribronchial and mediastinal lymph nodes from patients with T1, N0, M0 pulmonary adenocarcinomas. Am J Surg Pathol 24 (2000) 274-279
14. Izbicki J.R., Passlick B., Hosch S.B., Kubuschock B., Schneider C., Busch C., et al. Mode of spread in the early phase of lymphatic metastasis in non-small-cell lung cancer: significance of nodal micrometastasis. J Thorac Cardiovasc Surg 112 (1996) 623-630
15. Nagatani S., Shimada Y., Li Z., Kaganoi J., Kan T., Maeda M., et al. Validation of intra-operative detection of paratracheal lymph node metastasis using real-time RT-PCR targeting esophageal squamous cell carcinoma. Jpn J Clin Oncol 33 (2003) 549-555
16. Ishida M., Kitamura K., Kinoshita J., Sasaki M., Kuwahara H., and Sugimachi K. Detection of micrometastasis in the sentinel lymph nodes in breast cancer. Surgery 131 1 (Suppl.) (2002) S211-S216
17. Benlloch S., Galbis J., Alenda C., Peiró E., Rodriguez-Paniagua J., Sanchez-Paya J., et al. P-649 Role of CEA, PLUNC and CK19 mRNA expression in lymph nodes from resected stage I non-small cell lung cancer (NSCLC) patients as markers of occult micrometastasis: a pilot study. Lung Cancer 49 2 (Suppl.) (2005) S289
18. Krismann M., Todt B., Schroder J., Gareis D., Muller K.M., Seeber S., et al. Low specificity of cytokeratin 19 reverse transcriptase-polymerase chain reaction analyses for detection of hematogenous lung cancer dissemination. J Clin Oncol 13 (1995) 2769-2775
19. Le Pimpec-Barthes F., Danel C., Lacave R., Ricci S., Bry X., Lancelin F., et al. Association of CK19 mRNA detection of occult cancer cells in mediastinal lymph nodes in non-small cell lung carcinoma and high risk of early recurrence. Eur J Cancer 41 (2005) 306-312
20. Niki T., Iba S., Tokunou M., Yamada T., Matsuno Y., and Hirohashi S. Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma. Clin Cancer Res 6 (2000) 2431-2439
21. Tamura M., and Ohta Y. Serum vascular endothelial growth factor-C level in patients with primary nonsmall cell lung carcinoma: a possible diagnostic tool for lymph node metastasis. Cancer 98 (2003) 1217-1222
22. Ohta Y., Endo Y., Tanaka M., Shimizu J., Oda M., Hayashi Y., et al. Significance of vascular endothelial growth factor messenger RNA expression in primary lung cancer. Clin Cancer Res 2 (1996) 1411-1416
23. Futamura M., Takagi Y., Koumura H., Kida H., Tanemura H., Shimokawa K., et al. Spread of colorectal cancer micrometastases in regional lymph nodes by reverse transcriptase-polymerase chain reactions for carcinoembryonic antigen and cytokeratin 20. J Surg Oncol 68 (1998) 34-40
24. Wallace M.B., Block M.I., Gillanders W., Ravenel J., Hoffman B.J., Reed C.E., et al. Accurate molecular detection of non-small cell lung cancer metastases in mediastinal lymph nodes sampled by endoscopic ultrasound-guided needle aspiration. Chest 127 (2005) 430-437
25. Naruke T., Suemasu K., and Ishikawa S. Lymph node mapping and curability at various level of metastasis in resected lung cancer. J Thorac Cardiovasc Surg 76 (1978) 832-839